BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23973442)

  • 1. Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
    Kuang X; Chen YS; Wang LF; Li YJ; Liu K; Zhang MX; Li LJ; Chen C; He Q; Wang Y; Du JR
    Neurobiol Aging; 2014 Jan; 35(1):169-78. PubMed ID: 23973442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated klotho up-regulation improves aging-related memory deficits and oxidative stress in senescence-accelerated mouse prone-8 mice.
    Zhou HJ; Zeng CY; Yang TT; Long FY; Kuang X; Du JR
    Life Sci; 2018 May; 200():56-62. PubMed ID: 29544758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho upregulation contributes to the neuroprotection of ligustilide against cerebral ischemic injury in mice.
    Long FY; Shi MQ; Zhou HJ; Liu DL; Sang N; Du JR
    Eur J Pharmacol; 2018 Feb; 820():198-205. PubMed ID: 29233659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroxystilbene glucoside extends mouse life span via upregulating neural klotho and downregulating neural insulin or insulin-like growth factor 1.
    Zhou X; Yang Q; Xie Y; Sun J; Hu J; Qiu P; Cao W; Wang S
    Neurobiol Aging; 2015 Mar; 36(3):1462-70. PubMed ID: 25595496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
    Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
    Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice.
    Zhu WL; Zheng JY; Cai WW; Dai Z; Li BY; Xu TT; Liu HF; Liu XQ; Wei SF; Luo Y; Wang H; Pan HF; Wang Q; Zhang SJ
    Aging (Albany NY); 2020 Feb; 12(4):3175-3189. PubMed ID: 32065782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice.
    Tan MS; Yu JT; Jiang T; Zhu XC; Guan HS; Tan L
    J Alzheimers Dis; 2014; 38(3):633-46. PubMed ID: 24047617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice.
    Zeng CY; Yang TT; Zhou HJ; Zhao Y; Kuang X; Duan W; Du JR
    Neurobiol Aging; 2019 Jun; 78():18-28. PubMed ID: 30851437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
    J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
    Giuliani D; Bitto A; Galantucci M; Zaffe D; Ottani A; Irrera N; Neri L; Cavallini GM; Altavilla D; Botticelli AR; Squadrito F; Guarini S
    Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice.
    Piao SG; Kang SH; Lim SW; Chung BH; Doh KC; Heo SB; Jin L; Li C; Yang CW
    Transplantation; 2013 Jul; 96(2):146-53. PubMed ID: 23765110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
    Nakajima A; Aoyama Y; Nguyen TT; Shin EJ; Kim HC; Yamada S; Nakai T; Nagai T; Yokosuka A; Mimaki Y; Ohizumi Y; Yamada K
    Behav Brain Res; 2013 Aug; 250():351-60. PubMed ID: 23714077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.
    Sajan M; Hansen B; Ivey R; Sajan J; Ari C; Song S; Braun U; Leitges M; Farese-Higgs M; Farese RV
    Diabetes; 2016 Jul; 65(7):1892-903. PubMed ID: 26895791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of TAT-haFGF(₁₄₋₁₅₄) attenuates disease progression in a mouse model of Alzheimer's disease.
    Lou G; Zhang Q; Xiao F; Xiang Q; Su Z; Zhang L; Yang P; Yang Y; Zheng Q; Huang Y
    Neuroscience; 2012 Oct; 223():225-37. PubMed ID: 22885230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.